Source: The Lancet Oncology. Unidade: FMRP
Subjects: CARCINOMA, NEOPLASIAS OVARIANAS, QUIMIOTERAPIA, CIRURGIA
ABNT
VERGOTE, Ignace et al. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup. The Lancet Oncology, v. 23, n. 8, p. e374-e384, 2022Tradução . . Disponível em: https://doi.org/10.1016/S1470-2045(22)00139-5. Acesso em: 20 ago. 2024.APA
Vergote, I., Gonzalez-Martin, A., Lorusso, D., Gourley, C., Mirza, M. R., Kurtz, J. -E., et al. (2022). Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup. The Lancet Oncology, 23( 8), e374-e384. doi:10.1016/S1470-2045(22)00139-5NLM
Vergote I, Gonzalez-Martin A, Lorusso D, Gourley C, Mirza MR, Kurtz J-E, Okamoto A, Moore K, Kridelka F, Reis FJC dos. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup [Internet]. The Lancet Oncology. 2022 ; 23( 8): e374-e384.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1016/S1470-2045(22)00139-5Vancouver
Vergote I, Gonzalez-Martin A, Lorusso D, Gourley C, Mirza MR, Kurtz J-E, Okamoto A, Moore K, Kridelka F, Reis FJC dos. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup [Internet]. The Lancet Oncology. 2022 ; 23( 8): e374-e384.[citado 2024 ago. 20 ] Available from: https://doi.org/10.1016/S1470-2045(22)00139-5